76 related articles for article (PubMed ID: 30237140)
21. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
[TBL] [Abstract][Full Text] [Related]
22. iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine.
Pandey S; Jirásko M; Lochman J; Chvátal A; Chottova Dvorakova M; Kučera R
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143270
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
Kee TR; Espinoza Gonzalez P; Wehinger JL; Bukhari MZ; Ermekbaeva A; Sista A; Kotsiviras P; Liu T; Kang DE; Woo JA
Front Aging Neurosci; 2021; 13():660843. PubMed ID: 33967741
[TBL] [Abstract][Full Text] [Related]
24. A compendious summary of Parkinson's disease patient-derived iPSCs in the first decade.
Ren C; Wang F; Guan LN; Cheng XY; Zhang CY; Geng DQ; Liu CF
Ann Transl Med; 2019 Nov; 7(22):685. PubMed ID: 31930086
[TBL] [Abstract][Full Text] [Related]
25. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
[TBL] [Abstract][Full Text] [Related]
27. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
[TBL] [Abstract][Full Text] [Related]
28. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
[TBL] [Abstract][Full Text] [Related]
29. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP
Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313
[TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
31. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
32. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
33. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]